awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36090532-31DFA3EC-4CDA-4F48-AA0C-36B96089BAEB
Q36090532-31DFA3EC-4CDA-4F48-AA0C-36B96089BAEB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36090532-31DFA3EC-4CDA-4F48-AA0C-36B96089BAEB
Preclinical and clinical experience with fulvestrant (Faslodex) in postmenopausal women with hormone receptor-positive advanced breast cancer.
P2860
Q36090532-31DFA3EC-4CDA-4F48-AA0C-36B96089BAEB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36090532-31DFA3EC-4CDA-4F48-AA0C-36B96089BAEB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4345da775b6258f0b38af51daaae7487771d95a3
P2860
Postmenopausal women who progress on fulvestrant ('Faslodex') remain sensitive to further endocrine therapy.